Gemcitabine Plus Cisplatin Versus Gemcitabine Plus Carboplatin in Triple Negative Breast Cancer (TNBC)
NCT02341911
·
clinicaltrials.gov ↗
PHASE2
Phase
UNKNOWN
Status
150
Enrollment
OTHER
Sponsor class
Conditions
Breast Cancer
Interventions
DRUG:
Gemcitabine,cisplatin
DRUG:
Gemcitabine,carboplatin
Sponsor
Fudan University